PRKAA1 and metabolic dysfunction-associated steatotic liver disease: We constructed a NAFLD model of VEGFB gene suppression induced by HFD and PA solution, and clarified the process and mechanism of VEGFB participating in NAFLD fatty acid oxidation and lipid synthesis via acting on the AMPK signaling pathway at the animal and cell level.